Persistent HPV16 E7 Expression Establishes a Preconditioned Epithelial State and Reveals Amplified Transcriptional Responses in Females During Oral Carcinogenesis

Cancer of the head and neck, a group of diseases that strike the mouth and throat, does not arise from a single cause. For decades, doctors have recognized two distinct paths leading to these tumors. One path is driven by long-term exposure to harsh chemicals found in tobacco and alcohol, which damage the DNA of cells in the lining of the mouth. The other path is driven by a common virus called human papillomavirus, or HPV, which inserts its own genetic instructions into healthy cells, forcing them to grow out of control. While these two routes lead to the same destination—a dangerous cancer—they were long thought to travel through different biological landscapes. A critical question remained unanswered: does the virus change the terrain of the mouth before the cancer even appears, and does the body's sex, male or female, change how the cells react to this viral invasion? Understanding these early shifts is vital because the environment in which a tumor begins often dictates how it behaves and how well a patient survives.

A team of researchers at The University of Queensland set out to map this hidden terrain. They focused on a specific viral protein, HPV16 E7, which acts like a master switch, telling cells to divide rapidly. To see what happens before a tumor forms, they used a specialized mouse model that carries this viral switch in its mouth lining. They compared these mice to normal mice, observing the mouth tissue before and after exposing both groups to a chemical known to cause cancer, similar to how tobacco damages human tissue. The scientists also paid close attention to the difference between male and female mice, a factor often overlooked in early cancer studies. By examining the cells under microscopes, counting immune cells, and reading the genetic instructions inside the cells, they discovered that the virus does more than just speed up cell growth; it fundamentally rewrites the rules of the tissue environment long before cancer is visible.

The researchers found that the presence of the viral protein created a state of constant readiness in the mouth lining. Even before any cancer-causing chemical was introduced, the mouth tissue of the virus-carrying mice was thicker and filled with more dividing cells than the tissue of normal mice. This was not just a matter of size; the genetic activity inside these cells had shifted dramatically. The cells were running programs associated with rapid division and inflammation, essentially putting the tissue on high alert. This state was accompanied by a reshuffling of the immune system. The mouth lining of the virus-carrying mice hosted a different mix of immune cells, with a notable increase in cells that act as messengers and a specific type of T cell that carries a "brake" signal, known as CTLA4. This signal tells the immune system to hold back, a mechanism that might help the virus hide from the body's defenses.

When the researchers introduced the cancer-causing chemical to the normal mice, their mouth tissue underwent a massive transformation. The cells scrambled to activate the same growth and inflammation programs that were already running in the virus-carrying mice. However, when the same chemical was given to the mice that already carried the viral protein, the tissue did not change much. It was as if the virus had already prepared the ground, so the chemical had little new work to do. The normal mice had to build a new house from scratch, while the virus-carrying mice were already living in a house that was being renovated. Despite these different molecular journeys, both groups of mice eventually developed tumors of similar severity and size. This revealed a crucial insight: the virus does not simply make cancer happen faster; it changes the very nature of the disease process, steering the tissue down a different molecular path to reach the same destination.

The study also uncovered a striking difference between male and female mice. In both the normal and virus-carrying groups, the female mice showed a much louder and more complex reaction to the viral protein and the cancer-causing chemical. Their cells changed their genetic activity more extensively than the males did. This heightened responsiveness was seen in both the immune system and the tissue itself, suggesting that biological sex plays a significant role in how the mouth lining adapts to viral threats and chemical injury. While the male and female mice eventually developed similar tumors, the path the females took involved a broader and more intense reorganization of their cells.

To ensure these findings were relevant to humans, the researchers compared their mouse data with genetic records from human patients with head and neck cancer. They found a strong match between the patterns they saw in the mice and the patterns found in human tumors caused by the virus. The genetic programs active in the virus-carrying mice closely mirrored those in human patients with HPV-positive cancer, while the patterns in the normal mice matched those in patients with virus-negative cancer. This cross-species agreement suggests that the early changes observed in the mice are not just a laboratory curiosity but reflect the real biological events that occur in human mouths.

The work concludes that persistent infection with the viral protein establishes a unique, pre-conditioned state in the mouth lining. This state is characterized by rapid cell growth, inflammation, and a reshaped immune environment that is different from the one seen in cancer caused by chemicals alone. The virus appears to redirect the course of carcinogenesis, creating a distinct biological context in which the disease evolves. Furthermore, the study highlights that the body's sex influences this process, with females showing a more robust transcriptional response to both the virus and chemical injury. These findings suggest that treating or preventing these cancers may require strategies that account for the specific molecular landscape created by the virus and the biological sex of the patient, rather than treating all head and neck cancers as a single, uniform disease.